Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01305694

Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. (MSC)

PhaseⅠ/ⅡTrial of Bone Marrow Derived Mesenchymal Stem Cell Transplantation From Related Donor to Patients With Relapsed/Refractory Aplastic Anemia.

Sponsor: Guangdong Prevention and Treatment Center for Occupational Diseases

Conditions Aplastic Anemia

Interventions bone marrow derived mesenchymal stem cells

Updated 4 times since 2017 Last updated: Feb 28, 2011 Started: Feb 28, 2011 Primary completion: Jun 30, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Aplastic Anemia, this trial is ongoing. The trial is conducted by Guangdong Prevention and Treatment Center for Occupational Diseases and has accumulated 4 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangdong Prevention and Treatment Center for Occupational Diseases
Guangzhou General Hospital of Guangzhou Military Command
Guangzhou Municipal Twelfth People's Hospital

Data source: Guangzhou General Hospital of Guangzhou Military Command

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China